openPR Logo
Press release

Roche, AstraZeneca Market Share in North America and Europe PEGylated Drugs Market|Key Players: Pfizer, Amgen, Biogen

01-04-2019 06:35 PM CET | Health & Medicine

Press release from: Global Market Insights

North America and Europe PEGylated Drugs Market

North America and Europe PEGylated Drugs Market

Global North America and Europe PEGylated Drugs Market set to exceed USD 10.5 billion by 2024; according to a new research report by Global Market Insights.

Increasing R&D investment of biotechnology & pharmaceutical companies to develop enhanced PEGylated drugs for treatment of various chronic diseases along with rising occurrence of chronic ailments in developed regions will propel PEGylated drugs market growth over the forecast period. Major advancements in biologics sector including advances in drug antibody conjugates, and immunotherapies will positively impact market growth.

Moreover, rising incidences of chronic ailments and increasing death rates associated with cancer in Canada will propel industry growth. However, the side-effects associated with pegylated drugs along with drug failure will impede PEGylated drugs market growth over the forecast timeframe.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2511

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Roche
• AstraZeneca
• Pfizer
• Amgen
• Biogen
• Novo Nordisk
• UCB
• Merck KGaA

Cancer segment held over 60% of the overall market share in 2017 due to growing prevalence of the disease creating a demand for the development of effective drugs. Benefits offered by PEGylated drugs such as reduced proteolytic degradation along with minimized immunogenicity leading to enhanced therapeutic efficacy will propel market growth. Increasing areas of applications as well as rising adoption of PEGylated drugs to treat various types of cancer will stimulate business growth.

Hepatitis segment size was USD 156 million in 2017 and is anticipated to follow a declining trend over the forecast period. However, increasing focus of industry players to develop pegylated drugs used for the treatment of such chronic conditions will contribute to market growth. For instance, launch of Pegasys drug used for treating Hepatitis C in adult patients will fuel market growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2511

North America & Europe PEGylated Drugs Market by Disease Indication
o Cancer
o Hepatitis
o Multiple sclerosis
o Gastrointestinal disorders
North America & Europe PEGylated Drugs Market by Type
o Monoclonal antibodies (mAbs)
o Colony stimulating factors
o Interferons

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roche, AstraZeneca Market Share in North America and Europe PEGylated Drugs Market|Key Players: Pfizer, Amgen, Biogen here

News-ID: 1472468 • Views: 148

More Releases from Global Market Insights

Metalworking fluids market poised to gain impetus from aerospace sector
Metalworking fluids have been playing an invaluable role in a range of metalworking processes across applications, such as milling, forming, turning and grinding. The innate ability of metalworking fluids (MWF) to lubricate helps reduce loads for tools, machine tools and workpieces. Metal working fluids have become popular as coolants, chip removers, and lubricants at the time of machine operations. Several manufacturers are using MWFs to boost durability of machine tools and
Graphene Market 2023: Industry Demand, Growth, Analysis & Forecast
According to a report published by Global Market Insights Inc., the global graphene market size was estimated to be worth $35 million in 2018 and is expected to hit $406 million by 2026, registering an annual compound growth rate over 35% from 2019 to 2025. The report offers a comprehensive analysis of the key investment pockets, market size & estimations, drivers & opportunities, top winning strategies, market trends, and competitive
Bitumen Market Report 2018 and Future Opportunity Assessment 2025
Bitumen Market share is expected to cross USD 112 billion by 2025; according to a new research report by Global Market Insights, Inc. In construction sector, bitumen is among the major raw materials used in manufacturing water tanks, dams and bridges since it provides high viscosity, stickiness and water resistance to the structure. The escalating number of property renovation projects and modern construction systems especially in North America & Europe having
Hydrogen peroxide market Research 2022: Region Wise Analysis of Top Players in M …
Hydrogen Peroxide Market size was USD 3.89 billion in 2015 and is forecast to grow at more than 5% by 2024; according to a new research report by Global Market Insights, Inc. Rising paper & pulp industry is expected to be the major driver for global hydrogen peroxide market size in the upcoming years. Applications for brightening of deinked papers will favor industry demand, global paper & pulp industry was worth

All 5 Releases


More Releases for PEGylated

PEGylated Proteins Market Key highlights of the industry 2025
Global PEGylated Proteins Market: Snapshot The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations
PEGylated Proteins Market Striking over 2024
Global PEGylated Proteins Market: Snapshot The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations
PEGylated Proteins Market to See Incredible Growth
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
Segment-level analysis On PEGylated Proteins Market
Global PEGylated Proteins Market was worth USD 690.6 million in 2016 and estimated to be growing at a CAGR of 10.50%, to reach USD 1.137 billion by 2021. The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins.
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
PEGylated Proteins Market Research Report 2016-2024
The PEGylated Proteins Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation.PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic